DENVER, July 11 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. , an international e-Health, medical information technology company, today announced that the United States Patent and Trademark Office will be issuing a patent for SafeTrace Tx(R), its proprietary transfusion software, which is located at more than 337 sites in the United States and abroad. Issuance of a patent for SafeTrace Tx is significant, demonstrating that software developed by Global Med’s Wyndgate Technologies(R) division contains distinctive features which separate it from other blood management software programs.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
SafeTrace Tx is innovative blood management software which helps to raise the standard of care for patients, through improved safety, reduced waste and increased efficiency. The ability of SafeTrace Tx to handle remote crossmatching of blood is among the features covered by the patent announcement. The software enables laboratory staff to more effectively manage orders and to provide just-in-time inventory management of blood products while streamlining laboratory workload and expense. Transfusion services have reported cost reductions by using SafeTrace Tx to optimize operations and increase efficiency.
Mick Ruxin, M.D., Chairman and CEO, stated, “The Institute for Transfusion Medicine in Pittsburgh, along with many other Wyndgate customers, has been using remote crossmatch for years to facilitate just-in-time inventory management. This feature helps them to streamline their operations and increase efficiencies. By using the newly patent-approved remote crossmatch function, SafeTrace Tx helps to prevent excess blood waste by selecting the best inventory for transfusion from any of their networked facilities.”
Thomas F. Marcinek, President and Chief Operating Officer for Wyndgate Technologies, further stated, “As the inventors of patented software, Wyndgate is now in a stronger position in the blood management system marketplace. We are looking forward to adding to our growing list of customers in the United States and abroad who have selected our products to manage their transfusion services.” Mr. Marcinek added, “Like the facilities we serve, we are committed to high quality patient care and safety through the effective application of technology.”
About Global Med Technologies, Inc.
Global Med Technologies, Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate’s products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate’s products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system and the SafeTrace Tx(R) advanced transfusion management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.
For more information about Global Med’s products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com, http://www.peoplemed.com and http://www.wyndgate.com.
This news release may include statements that constitute forward-looking statements, usually containing the words “believe,” “estimate,” “project,” “expects” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
Photo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comGlobal Med Technologies, Inc.
CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies, Inc.,+1-303-238-2000; or investors, Paul Holm of H.L. Lanzet, +1-212-888-4570,paulmholm@gmail.com, for Global Med Technologies(R), Inc.
